Table 18:
LAAC Device–Specific Costs Used in the Economic Model
| Variable | Unit Cost ($) | Standard Deviation | Source |
|---|---|---|---|
| LAAC Surgery–Specific Costs | |||
| Device | 10,000 | 2,000 | Manufacturer (Boston Scientific Corporation) |
| Physician feesa | 1,194 | – | Schedule of Benefits,72 expert opinion |
| Anesthesiologist fees | 255 | – | Schedule of Benefits72 |
| Overnight hospitalization | 1,773 | 355 | Saw et al, 201636 |
| Nursing fees | 1,750 | 350 | Saw et al, 201636 |
| Catheterization lab fees | 3,000 | 600 | Expert opinion |
| Follow-up TEE | 271 | – | Schedule of Benefits72 |
| Surgical Adverse Event Costs | |||
| Pericardial effusion (ICD 313) | 6,422 | 7,531 | Ontario Case Costing Initiative73 |
| Device embolization (ICD T82.8) | 10,217 | 12,412 | Ontario Case Costing Initiative73 |
Abbreviations: ICD, International Classification of Diseases; LAAC, left atrial appendage closure; TEE transesophageal echocardiography.
a
Includes fees for transseptal left heart catheterization (Z441), angiogram (G297), percutaneous transluminal catheter-assisted closure for arterial septal defects (Z466), surgical assistant time, and initial TEE (G574, G575, G585, G581, G580).